Net Cash Provided by (Used in) Financing Activities of CytoDyn Inc. from 31 Aug 2010 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CytoDyn Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Aug 2010 to 31 Aug 2025.
  • CytoDyn Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Aug 2025 was $121,000, a 101% decline year-over-year.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,854,000, a 7.6% decline from 2023.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11,748,000, a 61% decline from 2022.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $29,927,000, a 38% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CytoDyn Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $121,000 -$9,788,000 -101% 01 Jun 2025 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q3 2024 $9,667,000 +$5,648,000 +141% 01 Jun 2024 31 Aug 2024 10-Q 10 Oct 2025 2026 Q1
Q3 2023 $4,019,000 -$7,500,000 -65% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q3 2022 $11,519,000 +$7,171,000 +165% 01 Jun 2022 31 Aug 2022 10-Q 23 Oct 2023 2024 Q1
Q3 2021 $4,348,000 -$40,580,000 -90% 01 Jun 2021 31 Aug 2021 10-Q/A 13 Oct 2022 2023 Q1
Q3 2020 $44,928,000 +$31,404,000 +232% 01 Jun 2020 31 Aug 2020 10-Q 12 Oct 2021 2021 Q1
Q3 2019 $13,524,000 +$1,033,110 +8.3% 01 Jun 2019 31 Aug 2019 10-Q 09 Oct 2020 2020 Q1
Q3 2018 $12,490,890 +$6,320,117 +102% 01 Jun 2018 31 Aug 2018 10-Q 08 Oct 2019 2020 Q1
Q3 2017 $6,170,773 01 Jun 2017 31 Aug 2017 10-Q 09 Oct 2018 2019 Q1
Q3 2013 $879,861 +$687,361 +357% 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2013 2014 Q1
Q3 2012 $192,500 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013 2014 Q1
Q3 2010 $20,200* 01 Jun 2010 31 Aug 2010 10-Q/A 30 Nov 2011 2012 Q1

CytoDyn Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,854,000 -$894,000 -7.6% 01 Jun 2024 31 May 2025 10-K 25 Jul 2025 2025 FY
2023 $11,748,000 -$18,179,000 -61% 01 Jun 2023 31 May 2024 10-K 25 Jul 2025 2025 FY
2022 $29,927,000 -$18,084,000 -38% 01 Jun 2022 31 May 2023 10-K 15 Aug 2024 2024 FY
2021 $48,011,000 -$89,335,000 -65% 01 Jun 2021 31 May 2022 10-K 14 Sep 2023 2023 FY
2020 $137,346,000 +$57,676,000 +72% 01 Jun 2020 31 May 2021 10-K 15 Aug 2022 2022 FY
2019 $79,670,000 +$26,923,000 +51% 01 Jun 2019 31 May 2020 10-K 15 Aug 2022 2022 FY
2018 $52,747,000 +$23,393,167 +80% 01 Jun 2018 31 May 2019 10-K 30 Jul 2021 2021 FY
2017 $29,353,833 +$10,476,444 +55% 01 Jun 2017 31 May 2018 10-K 14 Aug 2020 2020 FY
2016 $18,877,389 -$14,536,927 -44% 01 Jun 2016 31 May 2017 10-K 14 Aug 2019 2019 FY
2015 $33,414,316 01 Jun 2015 31 May 2016 10-K 27 Jul 2018 2018 FY
2012 $7,214,758 +$3,576,490 +98% 01 Jun 2012 31 May 2013 10-K 29 Aug 2013 2013 FY
2011 $3,638,268 +$1,474,825 +68% 01 Jun 2011 31 May 2012 10-K 29 Aug 2013 2013 FY
2010 $2,163,443 01 Jun 2010 31 May 2011 10-K 22 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.